Clindamycin and nicotinic neuromuscular transmission
- PMID: 10577648
- DOI: 10.1016/S0140-6736(99)02881-0
Clindamycin and nicotinic neuromuscular transmission
Abstract
Upon clindamycin treatment a patient with Parkinson's disease showed marked tremor improvement which may be explained by clindamycin's ability to inhibit in-vitro nicotinergic, but not muscarinic signal transmission.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical